gms | German Medical Science

63. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e. V. (GMDS)

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie

02. - 06.09.2018, Osnabrück

VANESA, facilitating the integrated analysis of gene and microRNA-based regulation

Meeting Abstract

Search Medline for

  • Christoph Brinkrolf - Department of Bioinformatics and Medical Informatics, Faculty of Technology, Bielefeld University, Bielefeld, Deutschland
  • Ralf Hofestaedt - Department of Bioinformatics and Medical Informatics, Faculty of Technology, Bielefeld University, Bielefeld, Deutschland
  • Jens Allmer - Applied Bioinformatics, Wageningen University and Research, BU Bioscience, Wageningen, Netherlands

Deutsche Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie. 63. Jahrestagung der Deutschen Gesellschaft für Medizinische Informatik, Biometrie und Epidemiologie e.V. (GMDS). Osnabrück, 02.-06.09.2018. Düsseldorf: German Medical Science GMS Publishing House; 2018. DocAbstr. 213

doi: 10.3205/18gmds174, urn:nbn:de:0183-18gmds1749

Published: August 27, 2018

© 2018 Brinkrolf et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution 4.0 License. See license information at http://creativecommons.org/licenses/by/4.0/.


Outline

Text

Introduction: A disease often manifests itself through protein dysregulation. MicroRNAs (miRNAs) are involved in the post-transcriptional regulation of protein abundance. Therefore, they have often been implicated with human disease. These approximately 22 nucleotides long, non-coding RNAs play active roles in fine tuning cellular processes. Currently, gene regulatory pathways are employed to analyze diseases using, for example, transcriptomics data. Current pathways as available on Reactome and KEGG, lack miRNA-based interactions and only model transcriptional gene regulation.

Methods: We adapted VANESA, a tool which enables the reconstruction of biological pathways and supports visualization, and simulation, to allow the integration of miRNAs into available pathways. Thereby, we were able to annotated the Measels and ALS pathways with miRNAs originating from genes and/or targeting genes in the respective pathways. MicroRNAs and their targets were curated into an integrated resources from miRBase, TarBase and miRTarBase.

Results: Here we detail how an integrated analysis of miRNA-bases and gene-based regulation can be performed with VANESA. The workflow will enable anyone to investigate integrated miRNA and gene regulation in human.

Discussion: This will help shed new light on disease mechanisms.

The authors declare that they have no competing interests.

The authors declare that an ethics committee vote is not required.